Related Parties (Details)	1 Months Ended			6 Months Ended
	Jun. 30, 2022 USD ($) Director shares	Apr. 30, 2022 USD ($)	Apr. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) Director shares	Dec. 31, 2021 Director shares
Related Party Transaction [Line Items]
Percentage of funding received			25.00%
Funding expected to be received			$ 125,000,000.0
Total funding received			$ 31,100,000
Common stock, shares outstanding | shares	148,395,282			148,395,282	147,719,523
Pfizer Inc [Member]
Related Party Transaction [Line Items]
Common stock, shares outstanding | shares	27,349,211			27,349,211	27,349,211
Number of members nominated to board of directors | Director	2			2	2
Bain Investor [Member]
Related Party Transaction [Line Items]
Common stock, shares outstanding | shares	60,632,356			60,632,356	60,632,356
Number of members nominated to board of directors | Director	4			4	4
Bain Funding Agreement [Member]
Related Party Transaction [Line Items]
Percentage of funding received		30.00%	25.00%
Period over which funding support received			4 years
Fees incurred			$ 100,000
Funding expected to be received			62,500,000
Total funding received		$ 18,750,000	$ 15,500,000
Research Collaboration and License Agreement [Member]
Related Party Transaction [Line Items]
Reimbursements for research services, contingent development milestone payment and single-digit royalty payments on net sales	$ 0
Management Agreement [Member]
Related Party Transaction [Line Items]
Management fee				$ 0